Patents by Inventor Ulf Peters

Ulf Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12116375
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: October 19, 2023
    Date of Patent: October 15, 2024
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 11939684
    Abstract: The present invention relates to the use of a composition of formula (I): Fe9-a-b-cNiaCobMcS8-dSed, wherein M stands for one or more elements having in the ionic state an effective ionic radius in the range of 70-92 pm, a is a number within the range of 2.5?a?3.5, more preferably 2.7?a?3.3, b is a number within the range of 1.5?b?5.0, more preferably 1.5?b?4.0, most preferably 2.5?b?3.5, c is a number within the range of 0.0?c?2.0, more preferably 0.0?c?1.0, d is a number within the range of 0.0?d?4.0, more preferably 0.0?d?1.0, wherein the sum of a, b and c is in the range of 5?a+b+c?8 and wherein ?90 wt. % of the composition is in the pentlandite phase for electrocatalytic splitting of water, preferably for hydrogen evolution reaction.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: March 26, 2024
    Assignee: TRIBOTECC GMBH
    Inventors: Lars Hensgen, Ulf-Peter Apfel, Mathias Smialkowski
  • Publication number: 20240067656
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: October 19, 2023
    Publication date: February 29, 2024
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 11891402
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: February 6, 2024
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 11718630
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: October 27, 2022
    Date of Patent: August 8, 2023
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Publication number: 20230242548
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: November 23, 2022
    Publication date: August 3, 2023
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Publication number: 20230135350
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: October 27, 2022
    Publication date: May 4, 2023
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 11603376
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: March 14, 2023
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Publication number: 20220106693
    Abstract: The present invention relates to the use of a composition of formula (I): Fe9-a-b-cNiaCobMcS8-dSed, wherein M stands for one or more elements having in the ionic state an effective ionic radius in the range of 70-92 pm, a is a number within the range of 2.5?a?3.5, more preferably 2.7?a?3.3, b is a number within the range of 1.5?b?5.0, more preferably 1.5?b?4.0, most preferably 2.5?b?3.5, c is a number within the range of 0.0?c?2.0, more preferably 0.0?c?1.0, d is a number within the range of 0.0?d?4.0, more preferably 0.0?d?1.0, wherein the sum of a, b and c is in the range of 5?a+b+c?8 and wherein ?90 wt. % of the composition is in the pentlandite phase for electrocatalytic splitting of water, preferably for hydrogen evolution reaction.
    Type: Application
    Filed: February 21, 2020
    Publication date: April 7, 2022
    Inventors: Lars HENSGEN, Ulf-Peter APFEL, Mathias SMIALKOWSKI
  • Publication number: 20210230183
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: March 25, 2021
    Publication date: July 29, 2021
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 11008334
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: May 18, 2021
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 10768322
    Abstract: Measured marine survey data can be processed analogously to modeled marine survey data analogously and a misfit can be calculated between the processed measured marine survey data and the processed modeled marine survey data. A model parameter in the modeled marine survey data can be updated based on the misfit. The model parameter can be a parameter of a subsurface location.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: September 8, 2020
    Assignee: PGS Geophysical AS
    Inventors: Ulf Peter Lindqvist, Lars Erik Magnus Bjornemo
  • Publication number: 20200255446
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: December 19, 2019
    Publication date: August 13, 2020
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 10716515
    Abstract: In some embodiments, a motion detection and correction system and/or device for tracking and compensating for patient motion during a medical imaging scan can be adapted to be integrated into a medical imaging scanner, such as an MRI scanner, or be adapted to retrofit a pre-existing medical imaging scanner. In certain embodiments, the motion detection system and/or device can comprise one or more mounting brackets and a motion correction device housing, which can further comprise one or more detector modules and a power unit. In further embodiments, the collected motion data can be further analyzed by an image processing unit of the motion tracking and/or correction system.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: July 21, 2020
    Assignee: Kineticor, Inc.
    Inventors: Ulf Peter Gustafsson, Andreas Wilhelm Dreher
  • Publication number: 20190119295
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: June 20, 2018
    Publication date: April 25, 2019
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 10175277
    Abstract: A system and method is provided for identifying degrading electrodes in a marine electromagnetic survey system. A system may comprise a sensor array operable for use in a marine electromagnetic survey system, wherein the sensor array comprises a plurality of electrodes. The system may comprise a shunt resistor connected to the electrodes and a processor operable to vary a resistance of the shunt resistor in the presence of a voltage across the electrodes. A method for identifying degrading electrodes may comprise measuring an electric field in a body of water with a pair of electrodes, wherein a shunt resistor is connected between the pair of electrodes. The method may comprise varying a resistance of the shunt resistor. The method may comprise measuring a voltage across the shunt resistor while varying the resistance of the shunt resistor to obtain measured voltages for different shunt resistor values.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: January 8, 2019
    Assignee: PGS Geophysical AS
    Inventors: Andras Robert Juhasz, Ulf Peter Lindqvist
  • Publication number: 20180246102
    Abstract: Provided herein are compositions, reactions mixtures, mutant Ras proteins, kits, substrates, and systems for selecting a Ras antagonist, as well as methods of using the same.
    Type: Application
    Filed: September 22, 2017
    Publication date: August 30, 2018
    Inventors: Matthew P. Patricelli, Ulf Peters, Liansheng Li, Pingda Ren, Yi Liu
  • Patent number: 10042073
    Abstract: Aspects described herein provide for a sensor assembly having an electrically isolated cable segment that may be used for geophysical prospecting. The sensor assembly generally includes a first cable segment comprising at least one electromagnetic (EM) sensor, and a second cable segment connected to the first cable segment and electrically isolated from the first cable segment. The second cable segment may be free of electrically conductive components. Alternatively, the second cable segment may have electrically conductive components that are not electrically connected to the first cable segment. The electrically isolated cable segment may reduce or eliminate undesired signal cross-feed from the EM source to the first cable segment, which may aid in maintaining data quality.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: August 7, 2018
    Assignee: PGS Geophysical AS
    Inventors: Lars Erik Magnus Björnemo, Ulf Peter Lindqvist
  • Patent number: 10023588
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: July 17, 2018
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Patent number: 9966167
    Abstract: The present invention provides a system and method for producing superconducting joints between superconductive segments of a Bi-2212 high-temperature superconducting (HTS) conductor, thereby eliminating the heat generating resistive joints that are commonly known in the art for connecting two or more smaller Bi-2212 conductive segments to create an Bi-2212 conductor of adequate length.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: May 8, 2018
    Assignee: The Florida State University Research Foundation, Inc.
    Inventors: Ulf Peter Trociewitz, Peng Chen, David K. Hilton, Dmytro V. Abraimov, William L. Starch, David C. Larbalestier, Jianyi Jiang, Eric E. Hellstrom, Ernesto S. Bosque, Maxime Matras